Overview
TGF-beta is a pleiotropic cytokine with dual roles: immunosuppressive (driving regulatory T cell [Treg] differentiation and maintaining immune tolerance) and pro-fibrotic (promoting extracellular matrix deposition, wound healing, and tissue fibrosis). In the WikiBiome context, TGF-beta sits at the intersection of microbiome-driven immune regulation, metal-induced fibrosis, and several disease signatures.
Microbiome Connection
- SCFA-driven Treg induction: Butyrate from faecalibacterium prausnitzii and other SCFA producers promotes TGF-beta-dependent Treg differentiation in the gut — the primary mechanism by which the microbiome maintains immune tolerance. Dysbiosis-driven butyrate loss reduces TGF-beta/Treg signaling, enabling inflammatory and autoimmune pathology.
- Endometriosis: TGF-beta drives endometrial stromal cell proliferation and fibrosis; gut microbiome disruption (antibiotic-induced) affects TGF-beta-dependent endometriotic lesion progression chadchan 2019 metronidazole antibiotics endometriosis gut microbiota.
- Hashimoto's thyroiditis: TGF-beta-mediated Treg/Th17 balance disrupted via gut microbiota-immune crosstalk pei 2024 immune cells gut microbiota hashimotos mendelian.
- ASD: Immunoregulatory TGF-beta pathways altered in ASD arteaga henriquez 2023 immunoregulatory anti inflammatory asd.
Metal Connection
- Cadmium and lead induce TGF-beta overexpression in kidney tissue, driving renal fibrosis mishra 2022 molecular mechanisms heavy metals ckd.
- The dual nature of TGF-beta means metal-driven TGF-beta elevation is simultaneously immunosuppressive (reducing pathogen clearance) and pro-fibrotic (causing tissue damage).
Cross-References
- immune balance — TGF-beta/Treg as immunoregulatory axis
- butyrate — SCFA-driven TGF-beta/Treg induction
- inflammation — TGF-beta as anti-inflammatory counterbalance
- endometriosis — TGF-beta-driven fibrosis in endometriotic lesions